BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 29733013)

  • 1. Neoadjuvant Radiochemotherapy for Patients with Locally Advanced Esophagogastric Junction Adenocarcinoma.
    Marica CD; Birlă R; Marica R; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2018; 113(2):192-201. PubMed ID: 29733013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The impact of preoperative radiochemotherapy on survival in advanced esophagogastric junction signet ring cell adenocarcinoma.
    Bekkar S; Gronnier C; Messager M; Robb WB; Piessen G; Mariette C;
    Ann Thorac Surg; 2014 Jan; 97(1):303-10. PubMed ID: 24200394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Outcomes of Neoadjuvant Chemoradiation in Patients with Gastro-esophageal Junction Adenocarcinoma: a Retrospective Cohort Study in Iran.
    Farhan F; Ghalehtaki R; Mahdavi-Seresht S; Meysamie A; Yamrali M; Farazmand B; Mohammadi N; Saraee E; Mir MR; Mir A; Lashkari M; Salarvand S; Esmati E; Samiei F
    J Gastrointest Cancer; 2019 Dec; 50(4):907-912. PubMed ID: 30402826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-Term Survival in Patients with Gastroesophageal Junction Cancer Treated with Preoperative Therapy: Do Thoracic and Abdominal Approaches Differ?
    Kneuertz PJ; Hofstetter WL; Chiang YJ; Das P; Blum M; Elimova E; Mansfield P; Ajani J; Badgwell B
    Ann Surg Oncol; 2016 Feb; 23(2):626-32. PubMed ID: 26564243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of postoperative TNM stages after neoadjuvant therapy on prognosis of adenocarcinoma of the gastro-oesophageal junction tumours.
    Thomaschewski M; Hummel R; Petrova E; Knief J; Wellner UF; Keck T; Bausch D
    World J Gastroenterol; 2018 Apr; 24(13):1429-1439. PubMed ID: 29632424
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adenocarcinoma of the esophagogastric junction: neoadjuvant radiochemotherapy and radical surgery : early results and toxicity.
    Leibl BJ; Vitz S; Schäfer W; Alfrink M; Gschwendtner A; Grabenbauer GG
    Strahlenther Onkol; 2011 Apr; 187(4):231-7. PubMed ID: 21437768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Staging and outcome depending on surgical treatment in adenocarcinomas of the oesophagogastric junction.
    Reeh M; Mina S; Bockhorn M; Kutup A; Nentwich MF; Marx A; Sauter G; Rösch T; Izbicki JR; Bogoevski D
    Br J Surg; 2012 Oct; 99(10):1406-14. PubMed ID: 22961520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Adenocarcinoma of the esophagus and esophagogastric junction in patients older than 70 years: results of neoadjuvant radiochemotherapy followed by transthoracic esophagectomy.
    Camerlo A; D'Journo XB; Ouattara M; Trousse D; Doddoli C; Thomas PA
    J Visc Surg; 2012 Jun; 149(3):e203-10. PubMed ID: 22633088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Long-term survival after eso-gastrectomy for esophagogastric junction adenocarcinoma--prospective study].
    Bîrlă R; Iosif C; Mocanu A; Gîndea C; Hoară P; Panaitescu E; Constantinoiu S
    Chirurgia (Bucur); 2008; 103(6):635-42. PubMed ID: 19274907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcomes of laparoscopic-assisted transhiatal esophagectomy for adenocarcinoma of the esophagus and esophago-gastric junction.
    Montenovo MI; Chambers K; Pellegrini CA; Oelschlager BK
    Dis Esophagus; 2011 Aug; 24(6):430-6. PubMed ID: 21309915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoadjuvant chemoradiotherapy improves survival in locally advanced adenocarcinoma of esophagogastric junction compared with neoadjuvant chemotherapy: a propensity score matching analysis.
    Li J; Zhao Q; Ge X; Song Y; Tian Y; Wang S; Liu M; Qiao X
    BMC Surg; 2021 Mar; 21(1):137. PubMed ID: 33731072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Individualized surgical strategies for cancer of the esophagogastric junction.
    Stein HJ; Feith M; Siewert JR
    Ann Chir Gynaecol; 2000; 89(3):191-8. PubMed ID: 11079787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor stage after neoadjuvant chemotherapy determines survival after surgery for adenocarcinoma of the esophagus and esophagogastric junction.
    Davies AR; Gossage JA; Zylstra J; Mattsson F; Lagergren J; Maisey N; Smyth EC; Cunningham D; Allum WH; Mason RC
    J Clin Oncol; 2014 Sep; 32(27):2983-90. PubMed ID: 25071104
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical strategies in true adenocarcinoma of the esophagogastric junction (AEG II): thoracoabdominal or abdominal approach?
    Blank S; Schmidt T; Heger P; Strowitzki MJ; Sisic L; Heger U; Nienhueser H; Haag GM; Bruckner T; Mihaljevic AL; Ott K; Büchler MW; Ulrich A
    Gastric Cancer; 2018 Mar; 21(2):303-314. PubMed ID: 28685209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Outcomes With Open and Minimally Invasive Ivor Lewis Esophagectomy After Neoadjuvant Therapy.
    Tapias LF; Mathisen DJ; Wright CD; Wain JC; Gaissert HA; Muniappan A; Lanuti M; Donahue DM; Morse CR
    Ann Thorac Surg; 2016 Mar; 101(3):1097-103. PubMed ID: 26652140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highlights of the EORTC St. Gallen International Expert Consensus on the primary therapy of gastric, gastroesophageal and oesophageal cancer - differential treatment strategies for subtypes of early gastroesophageal cancer.
    Lutz MP; Zalcberg JR; Ducreux M; Ajani JA; Allum W; Aust D; Bang YJ; Cascinu S; Hölscher A; Jankowski J; Jansen EP; Kisslich R; Lordick F; Mariette C; Moehler M; Oyama T; Roth A; Rueschoff J; Ruhstaller T; Seruca R; Stahl M; Sterzing F; van Cutsem E; van der Gaast A; van Lanschot J; Ychou M; Otto F;
    Eur J Cancer; 2012 Nov; 48(16):2941-53. PubMed ID: 22921186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Adenocarcinoma of the esophagogastric junction: retrospective analysis of 39 patients].
    Butte JM; Becker F; Visscher A; Waugh E; Meneses M; Court I; Parada H; DE LA Fuente H
    Rev Med Chil; 2010 Jan; 138(1):53-60. PubMed ID: 20361151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multimodal treatment of locally advanced esophageal adenocarcinoma: which regimen should we choose? Outcome analysis of perioperative chemotherapy versus neoadjuvant chemoradiation in 105 patients.
    Hoeppner J; Zirlik K; Brunner T; Bronsert P; Kulemann B; Sick O; Marjanovic G; Hopt UT; Makowiec F
    J Surg Oncol; 2014 Mar; 109(3):287-93. PubMed ID: 24277235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Surgical factors influence the outcome after Ivor-Lewis esophagectomy with intrathoracic anastomosis for adenocarcinoma of the esophagogastric junction: a consecutive series of 240 patients at an experienced center.
    Ott K; Bader FG; Lordick F; Feith M; Bartels H; Siewert JR
    Ann Surg Oncol; 2009 Apr; 16(4):1017-25. PubMed ID: 19189186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Classification, diagnosis and surgical treatment of carcinomas of the gastroesophageal junction.
    Mönig SP; Schröder W; Beckurts KT; Hölscher AH
    Hepatogastroenterology; 2001; 48(41):1231-7. PubMed ID: 11677937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.